CSL Biotherapies Products
| Annual Report Contents > Business Features > CSL Biotherapies Feature > CSL Biotherapies Products | |||||||||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
Vaccines |
For prevention of: |
|---|---|
| Fluvax® Pneumovax* 23 Menjugate* ADT® H-B-Vax* II PedvaxHIB* Vaqta* Varivax* Comvax* Q-Vax® MMR*II RotaTeq* Gardasil* |
Influenza Pneumococcal infection Meningococcal C disease Diphtheria and Tetanus Hepatitis B infection Haemophilus influenzae B Hepatitis A infection Varicella Haemophilus influenzae B and Hepatitis B infection Q-Fever Measles, mumps and rubella Rotavirus-induced gastroentiritis Cervical cancer |
Anti-infectives For treatment of:
| Flopen® Moxacin® Fucidin* BenPen® |
Severe staphylococcal infections Bacterial infections Bacterial infections Bacterial infections |
Other products |
For treatment of: |
|---|---|
| Tramal* Flomaxtra* Antivenoms Cervidil* Modavigil* Epi-Pen* Daivonex* Daivobet* |
Moderate to severe pain Benign prostatic hyperplasia Envenomation Complications during childbirth requiring induced labour Excessive daytime sleepiness in narcolepsy Severe allergic reactions Psoriasis Psoriasis |
Trademarks
| CSL, Bioplasma and ZLB are all trademarks of the CSL Group. | |
| ® | Registered trademark of CSL Limited or its affiliates. |
| ™ | Trademark of CSL Limited or its affiliates. |
| * | Trademarks of companies other than CSL and referred to in this Annual Report are listed below: |
| Merck & Co. Inc. | Comvax H-B-Vax II M-M-R II PedvaxHIB Pneumovax Vaqta Varivax RotaTeq Gardasil |
| Merck KGaA | EpiPen |
| Controlled Therapeutics (Scotland) Limited | Cervidil |
| Leo Pharmaceutical Products Limited AS | Daivonex Daivobet Fucidin |
| Yamanouchi Europe BV | Flomaxtra |
| Grunenthal GmbH | Tramal |
| Chiron SpA | Menjugate |
| Genelco SA | Modavigil |